Earningsreport

Q1/2023 3/31/2023 EPS -0.160 ZacksConsensus -0.140 ActVsEst (0.020) - Miss

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx